1. |
Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Ann Intern Med, 1994, 121(11): 894-895.
|
2. |
Andrew E, Anis A, Chalmers T, et al. A proposal for structured reporting of randomized controlled trials. JAMA, 1994, 272(24): 1926-1931.
|
3. |
Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 1996, 276(8): 637-639.
|
4. |
Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med, 2001, 134(8): 663-694.
|
5. |
Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ, 2010, 340: c332.
|
6. |
Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet, 2005, 365(9465): 1159-1162.
|
7. |
Plint AC, Moher D, Morrison A, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials. A systematic review. Med J Aust, 2006, 185(5): 263-267.
|
8. |
花放, 贺红. 个体内临床试验报告规范(CONSORT for WPT)解读. 中国循证医学杂志, 2018, 18(9): 1001-1006.
|
9. |
耿朝辉, 吴傅蕾, 王佳姝, 等. CONSORT-EHEALTH报告规范的解读与应用现状分析. 中国循证医学杂志, 2019, 19(6): 748-754.
|
10. |
杨文杰, 王丹丹, 黄利弢, 等. 健康公平相关随机对照试验的报告规范(CONSORT-Equity)扩展声明与解读. 中国循证医学杂志, 2019, 19(2): 238-247.
|
11. |
王瑞平, 李斌. 随机对照临床试验CONSORT声明解读. 上海医药, 2022, 43(5): 58-62.
|
12. |
庞博, 张晨瑶, 马毓聪, 等. 临床试验报告中的结局报告规范(CONSORT-Outcomes)2022扩展声明解读. 中国循证医学杂志, 2024, 24(11): 1337-1346.
|
13. |
王巍巍, 朱雪泉, 丰雷, 等. 析因随机试验报告CONSORT 2010扩展声明条目解读. 中国循证医学杂志, 2025, 25(1): 111-117.
|
14. |
Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomized trials. Nat Med, 2025, 31(6): 1776-1783.
|
15. |
Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomized trials. JAMA, 2025, 333(22): 1998-2005.
|
16. |
Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. Lancet, 2025, 14: S0140-6736.
|
17. |
Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ, 2025, 389: e081123.
|
18. |
Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ, 2025, 389: e081124.
|
19. |
Østengaard L, Barrientos A, Boutron I, et al. Development of a topic-specific bibliographic database supporting the updates of SPIRIT 2013 and CONSORT 2010. Cochrane Evid Synth Methods, 2024, 2(5): e12057.
|
20. |
Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PLoS Med, 2010, 7(2): e1000217.
|
21. |
Aaron SD, Vandemheen KL, Whitmore GA, et al. Early diagnosis and treatment of COPD and asthma - a randomized, controlled trial. N Engl J Med, 2024, 390(22): 2061-2073.
|
22. |
Ye H, Chu LH, Xie GH, et al. Effect of lateral versus supine positioning on hypoxaemia in sedated adults: multicentre randomised controlled trial. BMJ, 2025, 390: e084539.
|
23. |
Scott S. How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers. Philadelphia PA: American College of Physicians, 1997: 364.
|
24. |
Schulz KF. Subverting randomization in controlled trials. JAMA, 1995, 274(18): 1456-1458.
|